Triple Negative Breast Cancer, "I Won't Back Down!": Taking the Scenic Route at Komen's Global Race 2014...

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Sunday, June 29, 2014

Taking the Scenic Route at Komen's Global Race 2014...

Melissa Paskvan

Taking it all in as a blogger VIP special guest at Komen's 25th Anniversary of the Global Race in Washington DC on May 10, 2014. With over 15,000 race participants on the National Mall, you can really feel the enthusiasm of "IMPACT" among the enormous crowd during activities leading up to the race.

"...and now here we are today, the world's largest breast cancer organization fighting on all fronts." In community health, public policy, globally and of course research." - Nancy Brinker "...and as a member of the medical community that really stood out for me when I joined Komen our commitment to supporting the best science and the most dedicated brilliant researchers, we funded more breast cancer research than any other non-profit. We are looking for ways to prevent breast cancer and cure breast cancer and while we help many women who are facing disease right here and now today and we won't stop till we reach our goal!" -Dr. Judy Salerno

RACE FOR IMPACT, RACE FOR BREAKTHROUGHS, RACE FOR THE CURE!